Veracyte

ISIN US92337F1075

 | 

WKN A1W7EA

Market cap (in EUR)
2,558 m
Country
United States
Sector
Healthcare
Dividend yield
0.00%
 

Overview

Quote

Description

Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia. It intends to treat thyroid cancer, improve lung cancer screening, and clarify the diagnosis of idiopathic pulmonary fibrosis. The company was founded by Bonnie H. Anderson and Y. Douglas Dolginow on August 15, 2006 and is headquartered in South San Francisco, CA.
Show more Show less
Healthcare Healthcare Equipment Diagnostics and Drug Delivery Devices United States

Chart

Financials

Key metrics

Market capitalisation, EUR 2,558 m
EPS, EUR 0.34
P/B ratio 2.4
P/E ratio 100.5
Dividend yield 0.00%

Income statement (2024)

Revenue, EUR 412 m
Net income, EUR 22 m
Profit margin 5.41%

What ETF is Veracyte in?

There are 6 ETFs which contain Veracyte. All of these ETFs are listed in the table below. The ETF with the largest weighting of Veracyte is the Global X Telemedicine & Digital Health UCITS ETF Acc USD.
ETF Weight Investment focus Fund size (in m EUR)
Global X Telemedicine & Digital Health UCITS ETF Acc USD 5.23%
Equity
World
Health Care
5
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) 0.30%
Equity
United States
Health Care
Biotech
46
iShares S&P SmallCap 600 UCITS ETF 0.22%
Equity
United States
Small Cap
1,920
Vanguard ESG Global All Cap UCITS ETF (USD) Distributing 0.00%
Equity
World
Social/Environmental
490
Vanguard ESG North America All Cap UCITS ETF (USD) Distributing 0.01%
Equity
North America
Social/Environmental
25
JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist) 0.06%
Equity
United States
Small Cap
187

Prestaties

Rendementsoverzicht

YTD -14,89%
1 maand -11,60%
3 maanden +0,63%
6 maanden +55,34%
1 jaar -26,77%
3 jaar +29,55%
5 jaar -
Since inception -26,94%
2025 -1,31%
2024 +47,10%
2023 +14,30%
2022 -34,13%

Maandelijks rendement in een heat map

Risico

Risk metrics in this section:
 
  • Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
  • Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
  • Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.
ETF-rendementen zijn inclusief dividenduitkeringen (indien van toepassing).
Toon meer Toon minder

Risico-overzicht

Volatiliteit 1 jaar 52,20%
Volatiliteit 3 jaar 51,05%
Volatiliteit 5 jaar -
Rendement/Risico 1 jaar -0,51
Rendement/Risico 3 jaar 0,18
Rendement/Risico 5 jaar -
Maximaal waardedaling 1 jaar -55,03%
Maximaal waardedaling 3 jaar -55,64%
Maximaal waardedaling 5 jaar -
Maximaal waardedaling sinds aanvang -68,81%

Voortschrijdende volatiliteit over 1 jaar

— Gegevens verstrekt door Trackinsight, etfinfo, Xignite Inc., gettex, FactSet en justETF GmbH.

Standaard zijn ETF-rendementen inclusief dividenduitkeringen (indien van toepassing). Er is geen garantie voor de volledigheid, juistheid en correctheid van de getoonde informatie.